Longitudinal evaluation of anti-SARS-CoV-2 neutralizing antibody levels in 3-dose homologous (mRNA-1273- mRNA-1273- BNT162b2) vaccinated kidney transplant population: 18-month follow-up
KTRs receiving a three-dose mRNA COVID-19 vaccine regimen maintained strong nAB levels at 1-year follow-up, with comparable antibody levels seen between KTRs with prior infection + vaccination and vaccination alone.
Authors
- Indika Gawarammana (ORCID: https://orcid.org/0000-0001-6795-0113)
- Rajitha Asanga Abeysekera (ORCID: https://orcid.org/0000-0002-1654-1958)
- F. Noordeen (ORCID: https://orcid.org/0000-0002-2018-0606)
- K. Karunathilake (ORCID: https://orcid.org/0000-0001-9905-1948)
- Amali Karunathilaka
- Champa N. Ratnatunga (ORCID: https://orcid.org/0000-0002-2684-002X)
- Nishantha Nanayakkara (ORCID: https://orcid.org/0000-0002-3405-2912)
- Roshan Athula Kumara
- Chandana Keerthi Bandara
- Abdul Wazil
Institutions
- University of Peradeniya (LK)
- Teaching Hospital Kandy (LK)
Publication Details
- Journal
- IJID Regions
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.ijregi.2025.100767
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00